Editorial: The Honest Company’s “safer, healthier products” positioning has eroded substantially due to legal challenges, ingredient disputes and scrapes with competitors. It’s perhaps fitting at this point that the firm reportedly has been in acquisition talks with mainstream multinationals after years of masquerading as a uniquely principled outsider.
The Honest Company swept ever so sweetly onto the scene in 2011 with the promise of safer products for conscientious parents, capitalizing on rampant chemophobia that has bolstered the “natural” movement and impliedly casting the competition as disingenuous poisoners of unwitting families.
The strategy worked. The firm’s business ballooned from around $10m in sales in 2012 to $250m in 2014, leading to...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
